Caribou Historical Valuation

CRBU Stock  USD 2.02  0.04  2.02%   
Some fundamental drivers such as market cap or Caribou Biosciences enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Caribou Biosciences valuation indicators such as Working Capital of 0.0 or Enterprise Value of 730.8 M to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Caribou Biosciences's future value.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Caribou Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy Caribou Stock please use our How to Invest in Caribou Biosciences guide.

About Caribou Valuation Data Analysis

Valuation is the financial process of determining what Caribou Biosciences is worth. Caribou Biosciences valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Caribou Biosciences valuation ratios help investors to determine whether Caribou Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Caribou with respect to the benefits of owning Caribou Biosciences security.

Caribou Biosciences Valuation Data Chart

Market Cap is likely to gain to about 807.7 M in 2024. Enterprise Value is likely to gain to about 730.8 M in 2024

Enterprise Value

Enterprise Value (or EV) is usually referred to as Caribou Biosciences theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Caribou Biosciences debt, but would also pocket its cash. Enterprise Value is more accurate representation of Caribou Biosciences value than its market capitalization because it takes into account all of Caribou Biosciences existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Caribou Stock Analysis

When running Caribou Biosciences' price analysis, check to measure Caribou Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Caribou Biosciences is operating at the current time. Most of Caribou Biosciences' value examination focuses on studying past and present price action to predict the probability of Caribou Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Caribou Biosciences' price. Additionally, you may evaluate how the addition of Caribou Biosciences to your portfolios can decrease your overall portfolio volatility.